When you go into the bathroom, you might expect to see graffiti on the wall, right? I recently saw something very different that left me surprised. Around Sacramento a new kind of “writing on the wall” is showing up in some bathrooms in the form of essentially a paper advertisement taped to the stall wall …
Ad In Bathroom Stall: Your Stool Needed as Life-Saving Tool Read More »
You might enjoy the recommended reads below and find they surprise and educate you. Products in the pipeline – Ocata’s RPE by Alexey, a nice update on Ocata. Yes, we are seeing more attacks on academic freedom: guest post by historian of science and medicine. Guest piece by Alice Dreger on her new book, Galileo’s Middle Finger. …
Note that you can register for ISSCR Stockholm here and the early registration deadline is today, March 11. Even without ISSCR Stockholm is a city worth visiting! There is no Eiffel Tower, Colosseum or Big Ben but Stockholm is one of Europe’s best kept secrets and the most beautiful European city I have visited. This …
Tips for Visiting Stockholm During ISSCR 2015 by Heather Main Read More »
I recently interviewed leading genomics scientist George Church on the ways that trends in genomics are changing our world. We also discussed the possibility of heritable human genetic modification. These days we more often call this “CRISPR babies.” His answers suggest that genomics and gene editing are poised to radically change our world. They could literally …
George Church on Germline Human Genetic Modification Read More »
Here are some papers and news for weekend reads. What are you reading this weekend? What are your go-to stem cell journals? Hostile Takeover: Glioma Stem Cells Recruit TAMs to Support Tumor Progression by Yu Shi, Yi-fang Ping, Xia Zhang, Xiu-wu Bian in Cell Stem Cell. YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate self-renewal and …
Weekend Reads: Cool Papers, PubPeer, Jacob Hanna, & More Read More »
In the last few months the FDA has taken steps toward crystalizing regulatory oversight of stem cell and more broadly cell and tissue-based therapies. These steps come in the form of several draft guidances (see here, here, and here) . The Alliance for Regenerative Medicine (ARM) has responded to the draft guidance on Minimal Manipulation. For example, ARM has …
ARM Asks FDA for Clarification on Draft Guidance on Minimal Manipulation Read More »
It’s been exciting to watch the recent developments in using stem cells as the basis for treatments for Type I Diabetes. One of the major players in this arena is the privately-held company, ViaCyte. In this post, I interview ViaCyte President and CEO, Paul Laikind. The topics include their VC-01 product, the Encaptra device, an update on …
ViaCyte CEO Laikind Interview: Trial Update, Melton, & Future Read More »
The pieces on my radar screen to read in my ample spare time as I work the weekend on literally 5 different grants include these pieces: NECSS and SfSBM: A weekend of science and skepticism Breaking Down Fat: Trends in adipose cell-based clinical trials PubPeer Selections: Odd citations, “practice makes perfect,” a Nature update Right Turn: …
On Monday, I’ll be doing another Reddit AMA, this time on 3-person IVF also known as 3-parent IVF, mitochondrial transfer, 3-parent babies, etc. You can see the upcoming AMAs including mine listed in the right sidebar here. Mine will start at 10AM PST/1PM EST. I hope to discuss with a wide audience all the key …
Monday, March 2: My Reddit AMA on 3-Person IVF – Mitochondrial Transfer Read More »
What is one to do when the equivalent of the Surgeon General of the UK calls one’s concerns about something, in this case 3-person IVF, “bunk”? It sure gave me some pause. What’s going on? First, some brief background. The debate over 3-person IVF/mitochondrial transfer technology has been getting more heated. The epicenter for the discussion …
UK Surgeon General Calls My Concerns on 3-person IVF “Bunk” Read More »